Cg. Sotiriou et Jwm. Cheng, Beneficial effects of statins in coronary artery disease - Beyond loweringcholesterol, ANN PHARMAC, 34(12), 2000, pp. 1432-1439
OBJECTIVES: To review the benefits of statins in coronary artery disease ma
nagement beyond their cholesterol-lowering effects.
DATA SOURCES: A MEDLINE search (1966-May 2000) was conducted using the foll
owing terms: lovastatin, pravastatin, simvastatin, atorvastatin, fluvastati
n, cerivastatin, endothelium, plaque stabilization, antithrombotic effects.
STUDY SELECTION: English-language human studies and case reports.
DATA EXTRACTION: Studies published demonstrating other mechanisms of statin
s' clinical beneficial effects were evaluated and reviewed.
DATA SYNTHESIS: The understanding of the pharmacologic effects of stains ha
s led to the realization that the benefits of these agents extend beyond si
mply lowering cholesterol. These properties include beneficial effects on v
essel endothelial tissue; decreased low-density lipoprotein oxidation and i
nflammation; ability to stabilize atherosclerotic plaques and perhaps promo
te regression; proliferative effects on smooth-muscle growths, possibly str
engthening atherosclerotic plaques; antithrombotic effects by inhibiting pl
atelet aggregation and stimulation of fibrinolytic factors; and improvement
of blood viscosity and flow. With these actions, statins may benefit the s
ituation of long-term atherosclerotic plaque formation and the setting of a
cute coronary syndrome.
CONCLUSIONS: Further large-scale studies are needed to determine the clinic
al importance and validity of these postulated beneficial effects of statin
s.